Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Astrazeneca Company Profile

« Back to Dashboard

Summary for Applicant: Astrazeneca

Drug Master File Entries: (click here to view)6
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca Ab
dapagliflozin propanediol
TABLET;ORAL202293-001Jan 8, 2014RXNo7,851,502<disabled>Y <disabled>
Astrazeneca Ab
dapagliflozin propanediol
TABLET;ORAL202293-002Jan 8, 2014RXYes<disabled><disabled>
Astrazeneca Pharms
aclidinium bromide
POWDER, METERED;INHALATION202450-001Jul 23, 2012RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?